ARCHIVES

ORI Says COMS Study Coordinator Committed Scientific Misconduct

This article is from The Cancer Letter archive.

Vol. 22 No. 15 | April 12, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

April 3, 1992

NCI Takes Action Against Investigators Who Gave Drug Without An IND; M.D. Anderson Contract Canceled

August 28, 1981

NCI 1980s Challenge: Matching Schientific Priorities With Resources, DeVita Says At Swearing-In

August 15, 1980

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

ASCO Endorses Guideline for Molecular Testing

October 17, 2014

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001